208 related articles for article (PubMed ID: 27334367)
81. A-beta-subtype of ketosis-prone diabetes is not predominantly a monogenic diabetic syndrome.
Haaland WC; Scaduto DI; Maldonado MR; Mansouri DL; Nalini R; Iyer D; Patel S; Guthikonda A; Hampe CS; Balasubramanyam A; Metzker ML
Diabetes Care; 2009 May; 32(5):873-7. PubMed ID: 19228875
[TBL] [Abstract][Full Text] [Related]
82. Genetic and molecular insights into the role of PROX1 in glucose metabolism.
Lecompte S; Pasquetti G; Hermant X; Grenier-Boley B; Gonzalez-Gross M; De Henauw S; Molnar D; Stehle P; Béghin L; Moreno LA; Amouyel P; Dallongeville J; Meirhaeghe A
Diabetes; 2013 May; 62(5):1738-45. PubMed ID: 23274905
[TBL] [Abstract][Full Text] [Related]
83. Systems biology approach reveals genome to phenome correlation in type 2 diabetes.
Jain P; Vig S; Datta M; Jindel D; Mathur AK; Mathur SK; Sharma A
PLoS One; 2013; 8(1):e53522. PubMed ID: 23308243
[TBL] [Abstract][Full Text] [Related]
84. No association of the IRS1 and PAX4 genes with type I diabetes.
Bergholdt R; Brorsson C; Boehm B; Morahan G; Pociot F;
Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S49-53. PubMed ID: 19956100
[TBL] [Abstract][Full Text] [Related]
85. Inhibitory effect of pax4 on the human insulin and islet amyloid polypeptide (IAPP) promoters.
Campbell SC; Cragg H; Elrick LJ; Macfarlane WM; Shennan KI; Docherty K
FEBS Lett; 1999 Dec; 463(1-2):53-7. PubMed ID: 10601637
[TBL] [Abstract][Full Text] [Related]
86. C.487C>T mutation in PAX4 gene causes MODY9: A case report and literature review.
Zhang D; Chen C; Yang W; Piao Y; Ren L; Sang Y
Medicine (Baltimore); 2022 Dec; 101(51):e32461. PubMed ID: 36595822
[TBL] [Abstract][Full Text] [Related]
87. [Overexpression of PAX4 by gene therapy for type 1 diabetes treatment].
Perge K; Eljaafari A
Med Sci (Paris); 2020 May; 36(5):458-460. PubMed ID: 32452366
[No Abstract] [Full Text] [Related]
88. Conversion of Gastrointestinal Somatostatin-Expressing D Cells Into Insulin-Producing Beta-Like Cells Upon
Garrido-Utrilla A; Ayachi C; Friano ME; Atlija J; Balaji S; Napolitano T; Silvano S; Druelle N; Collombat P
Front Endocrinol (Lausanne); 2022; 13():861922. PubMed ID: 35573999
[TBL] [Abstract][Full Text] [Related]
89. Association of His1085His INSR gene polymorphism with type 2 diabetes in South Indians.
Bodhini D; Sandhiya M; Ghosh S; Majumder PP; Rao MR; Mohan V; Radha V
Diabetes Technol Ther; 2012 Aug; 14(8):696-700. PubMed ID: 22775283
[TBL] [Abstract][Full Text] [Related]
90. Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese Han population.
Liu S; Li K; Li T; Xiong X; Yao S; Chen Z; Wang C; Zhao B
DNA Cell Biol; 2013 Mar; 32(3):119-24. PubMed ID: 23402331
[TBL] [Abstract][Full Text] [Related]
91. The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cells.
Courtney M; Gjernes E; Druelle N; Ravaud C; Vieira A; Ben-Othman N; Pfeifer A; Avolio F; Leuckx G; Lacas-Gervais S; Burel-Vandenbos F; Ambrosetti D; Hecksher-Sorensen J; Ravassard P; Heimberg H; Mansouri A; Collombat P
PLoS Genet; 2013 Oct; 9(10):e1003934. PubMed ID: 24204325
[TBL] [Abstract][Full Text] [Related]
92. Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients.
Chen M; Hu C; Zhang R; Jiang F; Wang J; Peng D; Tang S; Sun X; Yan J; Luo Y; Bao Y; Jia W
Pharmacogenomics J; 2014 Oct; 14(5):488-92. PubMed ID: 24752311
[TBL] [Abstract][Full Text] [Related]
93. Defective insulin maturation in patients with type 2 diabetes.
Huang Y; Zhen J; Liu T; Wang J; Li N; Yang J; Liang R; Wang S; Liu M
Eur J Endocrinol; 2021 Sep; 185(4):565-576. PubMed ID: 34374650
[TBL] [Abstract][Full Text] [Related]
94. A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese.
Shimajiri Y; Sanke T; Furuta H; Hanabusa T; Nakagawa T; Fujitani Y; Kajimoto Y; Takasu N; Nanjo K
Diabetes; 2001 Dec; 50(12):2864-9. PubMed ID: 11723072
[TBL] [Abstract][Full Text] [Related]
95. Generation of animals allowing the conditional inactivation of the Pax4 gene.
Kordowich S; Serup P; Collombat P; Mansouri A
Transgenic Res; 2012 Dec; 21(6):1215-20. PubMed ID: 22717987
[TBL] [Abstract][Full Text] [Related]
96. Functional characterization of T2D-associated SNP effects on baseline and ER stress-responsive β cell transcriptional activation.
Khetan S; Kales S; Kursawe R; Jillette A; Ulirsch JC; Reilly SK; Ucar D; Tewhey R; Stitzel ML
Nat Commun; 2021 Sep; 12(1):5242. PubMed ID: 34475398
[TBL] [Abstract][Full Text] [Related]
97. The type 2 diabetes risk allele of TMEM154-rs6813195 associates with decreased beta cell function in a study of 6,486 Danes.
Harder MN; Appel EV; Grarup N; Gjesing AP; Ahluwalia TS; Jørgensen T; Christensen C; Brandslund I; Linneberg A; Sørensen TI; Pedersen O; Hansen T
PLoS One; 2015; 10(3):e0120890. PubMed ID: 25799151
[TBL] [Abstract][Full Text] [Related]
98. Functional annotation of sixty-five type-2 diabetes risk SNPs and its application in risk prediction.
Wu Y; Jing R; Dong Y; Kuang Q; Li Y; Huang Z; Gan W; Xue Y; Li Y; Li M
Sci Rep; 2017 Mar; 7():43709. PubMed ID: 28262806
[TBL] [Abstract][Full Text] [Related]
99. Restriction fragment length polymorphisms of the insulin gene hypervariable region in gestational onset diabetes mellitus.
Ober C; Wason CJ; Andrew K; Dooley S
Am J Obstet Gynecol; 1987 Dec; 157(6):1364-8. PubMed ID: 2892412
[TBL] [Abstract][Full Text] [Related]
100. ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response.
Adeyemo AA; Zaghloul NA; Chen G; Doumatey AP; Leitch CC; Hostelley TL; Nesmith JE; Zhou J; Bentley AR; Shriner D; Fasanmade O; Okafor G; Eghan B; Agyenim-Boateng K; Chandrasekharappa S; Adeleye J; Balogun W; Owusu S; Amoah A; Acheampong J; Johnson T; Oli J; Adebamowo C; ; Collins F; Dunston G; Rotimi CN
Nat Commun; 2019 Jul; 10(1):3195. PubMed ID: 31324766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
